Stock·NASDAQ·Industrials
CSX Corporation (CSX)
- Market cap
- $95.05B
- P/E
- 26.72
- Dividend yield
- 1.09%
- Street target
- $54.00median of 25 analysts
- 52-week range
- $33.63 $53.60
CSX stock forecast today
Where CSX stands today, and what CleaRank Financial AI makes of it.
CSX at a glance
CSX Corporation (CSX): Buy, 79/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($48.74 and $45.27).
- Earnings CSX beat estimates in 5 of its last 8 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $18.6M and bought $3.0M over the last 18 months.
- Valuation P/E of 26.7 against 34.0 for the Industrials sector: a discount to peers (-21%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates CSX Corporation (CSX) Buy with a model score of 79/100.
The trend adds the most to that score. The price is 13.34% above the 200-day average and 5.27% above the 50-day, and the 50-day is 7.66% above the 200-day, with the two averages standing at $48.74 and $45.27. The price also rose 42.01% over the past year.
Only on CleaRank
Figures we compute ourselves from CSX's own price, earnings and insider-filing history. Tap one to see it in context.
CSX stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $51.31 is 5.3% above the 50-day simple moving average of $48.74.Price above its 200-day average ›
The price is 13.3% above the 200-day simple moving average of $45.27.50-day average above the 200-day ›
The 50-day average ($48.74) is 7.7% above the 200-day average ($45.27), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 89% of its 52-week range, between $33.63 and $53.60.
CSX share price
Pick a period: each tab shows how far CSX has moved over it, to the last close.
Today's trading
Where CSX sits inside today's range and its 52-week range.
CSX fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 26.72 is 21.4% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 6.36 is 59.0% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $3.6B on revenue of $14.9B, a net margin of 24.0%.Beat estimates in most recent reports ›
CSX beat the EPS estimate in 5 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.09%, or $0.56 a share a year.
Key statistics
The headline figures for CSX.
As of October 26, 2026, CSX trades at $51.31, with a market value of $95.05B, a P/E ratio of 26.72 and a dividend yield of 1.09%.
What the numbers say
CleaRank Financial AI's reading of CSX's valuation, growth and risks.
CSX Corporation (CSX) trades at a P/E of 26.72, which is 22.2% below the 34.0 median P/E of Industrials stocks, a discount to peers.
Profitability is strong, with a net margin of 23.97%, an operating margin of 39.26% and a return on equity of 26.39%, which sits above the sector median of 17.8%. On the balance sheet, debt-to-equity stands at 1.35, and the trailing dividend yield is 1.09%, equal to $0.56 a share per year.
CSX's most recent quarterly report, released on October 21, 2026, topped the estimate by 7.55%. The company earned $0.57 a share where analysts had expected $0.53. In the first session after the report, the share price went up 6.76%.
The earnings record shows 5 beats in 8 reports, and every one of those beats was followed by a gain the next day. The April 22, 2026 report stands out among the earlier ones: a beat of 10.26%, after which the stock rose 6.95%. The consensus EPS estimate stands at $2.05 for this fiscal year and $2.33 for next, growth of 33.0% for the current year.
The price of CSX typically moves 1.63% on a given day, based on the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 1.20. Over the last 18 months, insiders sold $18.6M of stock and bought $3.0M. Insider sales are often planned in advance or made to cover taxes on vesting shares, so they tell an investor less than open-market purchases do.
CSX against the Industrials sector
How CSX compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: CSX trades at a notable discount to sector peers (-21%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 14, 2025, CSX has gained 65.4% against a gain of 18.8% for XLI.
Performance against XLI
CSX and the Industrials sector fund over the same days.
Revenue and earnings
How much CSX sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); CSX reported again on October 21, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue fell 3.1% in FY2025 to $14.1B, from $14.5B a year earlier.
Profit margin: The net margin was 20.5% in FY2025, down from 23.9% the year before.
Profitable: CSX earned $2.9B in FY2025.
Earnings reality check
Did CSX beat what analysts expected, and how did the stock react?
Earnings record: CSX beat the analyst estimate in 5 of the last 8 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 21, 2026after close | $0.53 | $0.57 | +7.55% | +6.76% | - |
| Jul 22, 2026after close | $0.52 | $0.54 | +3.85% | +5.77% | +1.62% |
| Apr 22, 2026after close | $0.39 | $0.43 | +10.26% | +6.95% | +3.47% |
| Jan 22, 2026after close | $0.41 | $0.39 | -4.88% | +2.40% | +5.84% |
| Oct 16, 2025after close | $0.42 | $0.44 | +4.76% | +1.69% | -1.28% |
| Jul 23, 2025after close | $0.42 | $0.44 | +4.76% | +0.09% | +0.92% |
| Apr 16, 2025after close | $0.37 | $0.34 | -8.11% | +1.21% | +2.89% |
| Jan 23, 2025after close | $0.42 | $0.42 | +0.00% | -2.91% | -2.41% |
As of October 26, 2026, CSX has beaten the analyst EPS estimate in 5 of its last 8 reported quarters and rose in the first trading session after every one of those beats; its latest report, on October 21, 2026, came in 7.55% above the estimate and the stock moved +6.76% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CSX AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 67.7, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 67.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of CSX
The score, the reasoning behind it, and what could move the price next.
CSX Corporation (CSX) is in an uptrend. Its price of $51.31 sits 5.27% above its 50-day average of $48.74 and 13.34% above its 200-day average of $45.27. The stock is close to the top of its 52-week range: the price is 4.27% below the high of $53.60 and 52.57% above the low of $33.63. The 50-day average is 7.66% above the 200-day, so the averages themselves point up as well.
The 14-day RSI of 67.7 is in the bullish zone, below the overbought line, and the MACD line is positive. The short and long run point different ways: the price rose 9.68% over the past month, fell 0.95% over the past three months and rose 42.01% over the past year. Volume in the last session ran 26.6% below its average, on a day the price rose 1.02%.
Earnings beat ›
The October 21, 2026 report beat the EPS estimate by 7.55%, and the share price rose 6.76% in the first session after it.
Source: Earnings report, October 21, 2026
Rating reaffirmed ›
Citigroup kept its Neutral rating on October 23, 2026.
Source: Analyst action, Citigroup, October 23, 2026
- Keep an eye on the two closest levels: the 52-week high at $53.60 sits above the price, and the 20-day EMA at $48.76 sits below it.
- A 14-day RSI of 67.7 sits in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- Following the October 21, 2026 report, the share price climbed 6.76% in the first session. Across the last 8 reports, CSX has beaten estimates in 5.
The uptrend rests on CSX staying above its 50-day average at $48.74 and its 200-day average at $45.27; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $48.76.
The next level above the price is the 52-week high of $53.60.
Technical indicators
Momentum and trend for CSX, from its daily closes.
As of October 26, 2026, with CSX at $51.31, its 14-day RSI is 67.7 (showing bullish momentum without being overbought), its 50-day simple moving average is $48.74 and its 200-day is $45.27.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CSX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, CSX's 1-year correlation of daily returns is +0.42 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.08 with Bitcoin (BTC) and +0.04 with gold (XAU).
CSX price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
17 of 25 analysts rate it a buy or strong buy, 6 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $54.00 is 5.2% above the price.More buy ratings than three months ago ›
17 of 25 rate it a buy now, against 17 of 25 three months ago.
CSX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 23, 2026 | Citigroup | Maintains | Neutral |
| Oct 22, 2026 | UBS | Maintains | Buy |
| Oct 22, 2026 | B of A Securities | Maintains | Buy |
| Oct 22, 2026 | RBC Capital | Maintains | Outperform |
| Oct 22, 2026 | TD Cowen | Maintains | Buy |
| Oct 22, 2026 | JP Morgan | Maintains | Overweight |
As of October 26, 2026, 25 Wall Street analysts cover CSX: 17 rate it a buy or strong buy, 6 a hold and 2 a sell or strong sell. Their 12-month price targets range from $32.00 to $60.00. The median CSX price target is $54.00, 5.2% above the price of $51.31.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CSX trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CSX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CSX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CSX tends to move, against the market and on its own.
CSX price history and drawdowns
CSX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.63% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 31.4%, from February 2020 to March 2020, regained by September 2020.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $59,341, against $42,015 in the S&P 500 (SPY).
CSX Drawdowns & Recovery
As of October 26, 2026, CSX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -31.4% (February 2020 to March 2020); it regained that peak by September 2020, 6 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CSX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CSX beat the S&P 500 over this period: $59,341 against $42,015.
A $10,000 investment in CSX in October 2016 would be worth about $59,341 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CSX, and which have not.
Strongest month, November: an average of +7.04%, up in 8 of 10 years.
Weakest month, March: an average of -2.78%, up in 4 of 10 years.
This month, October: has averaged +2.40%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CSX's strongest calendar month has been November (average +7.04%, up in 8 of 10 years) and its weakest March (average -2.78%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CSX stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CSX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CSX today could grow to about $14,546 by 2030 in the base case, with a 90th-percentile outcome near $29,549 and a 10th-percentile outcome around $7,160. The simulation models price only; at today's 1.09% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CSX Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $74.63 for CSX by 2030 in the base case, from $51.31 today (1.5x over 4 years). The 10th-percentile path ends near $36.74. These are outcomes of a Monte Carlo simulation run on CSX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $39.54 | $56.35 | $80.31 | |
| 2028 | $37.49 | $61.88 | $102 | |
| 2029 | $36.79 | $67.96 | $126 | |
| 2030 | $36.74 | $74.63 | $152 |
Method: a lognormal simulation of CSX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
CSX insider trading
What the people running the company have bought and sold.
CSX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $3.0M on the open market and sold $18.6M.
As of October 26, 2026, CSX insiders reported 9 open-market sales worth $18.6M and 2 open-market purchases worth $3.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Angela C Williams
Officer
|
Sell | 30.0K | $1.6M |
| Jul 24, 2026 | Michael S. Burns
Officer
|
Sell | 13.0K | $684.8K |
| Jul 24, 2026 | Michael S. Burns
Officer
|
Option | 13.0K | $344.5K |
| Jun 15, 2026 | J Steven Whisler
Director
|
Grant | 791 | $37.5K |
| Jun 3, 2026 | Kevin S Boone
Chief Financial Officer
|
Sell | 136.7K | $6.4M |
| Jun 3, 2026 | John J Zillmer
Director
|
Sell | 10.0K | $464.5K |
| Jun 3, 2026 | Kevin S Boone
Chief Financial Officer
|
Option | 136.7K | $3.2M |
| Mar 13, 2026 | J Steven Whisler
Director
|
Grant | 954 | $37.5K |
| Mar 6, 2026 | Stephen F Angel
Chief Executive Officer
|
Buy | 25.0K | $1.0M |
| Mar 2, 2026 | John J Zillmer
Director
|
Grant | 5.9K | - |
| Feb 26, 2026 | Stephen F Angel
Chief Executive Officer
|
Grant | 63.3K | - |
| Feb 26, 2026 | Ann Begeman
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Kevin S Boone
Chief Financial Officer
|
Grant | 15.2K | - |
| Feb 26, 2026 | Thomas P Bostick, PH.D.
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Michael S. Burns
Officer
|
Grant | 8.2K | - |
| Feb 26, 2026 | M Rizwan Chand
Officer
|
Grant | 11.7K | - |
| Feb 26, 2026 | Anne H Chow
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Michael A Cory
Chief Operating Officer
|
Grant | 15.2K | - |
| Feb 26, 2026 | Stephen Fortune
Chief Technology Officer
|
Grant | 10.9K | - |
| Feb 26, 2026 | Steven T Halverson
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Paul C. Hilal, J.D.
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Maryclare T Kenney
Officer
|
Grant | 9.4K | - |
| Feb 26, 2026 | David M Moffett
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Linda H Riefler
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | James L Wainscott
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | J Steven Whisler
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Angela C Williams
Officer
|
Grant | 1.9K | - |
| Feb 26, 2026 | John J Zillmer
Director
|
Grant | 10.3K | - |
| Feb 19, 2026 | Diana B Sorfleet
Officer
|
Sell | 90.0K | $3.7M |
| Feb 19, 2026 | Diana B Sorfleet
Officer
|
Option | 90.0K | $1.8M |
| Feb 3, 2026 | Stephen Fortune
Chief Technology Officer
|
Sell | 31.5K | $1.2M |
| Feb 3, 2026 | Stephen Fortune
Chief Technology Officer
|
Option | 31.5K | $996.2K |
| Jan 28, 2026 | Diana B Sorfleet
Officer
|
Sell | 66.7K | $2.5M |
| Jan 23, 2026 | Kevin S Boone
Chief Financial Officer
|
Grant | 3.1K | - |
| Jan 23, 2026 | Michael S. Burns
Officer
|
Grant | 298 | - |
| Jan 23, 2026 | Michael A Cory
Chief Operating Officer
|
Grant | 2.4K | - |
| Jan 23, 2026 | Stephen Fortune
Chief Technology Officer
|
Grant | 2.3K | - |
| Jan 23, 2026 | Maryclare T Kenney
Officer
|
Grant | 355 | - |
| Jan 23, 2026 | Diana B Sorfleet
Officer
|
Grant | 2.3K | - |
| Jan 23, 2026 | Angela C Williams
Officer
|
Grant | 336 | - |
| Dec 15, 2025 | J Steven Whisler
Director
|
Grant | 1.7K | $62.5K |
| Dec 4, 2025 | Paul C. Hilal, J.D.
Director
|
Grant | 10.0K | - |
| Nov 14, 2025 | Maryclare T Kenney
Officer
|
Grant | 1.3K | - |
| Oct 22, 2025 | Kevin S Boone
Officer
|
Sell | 31.1K | $1.1M |
| Oct 22, 2025 | Kevin S Boone
Officer
|
Option | 31.1K | $551.5K |
| Oct 20, 2025 | Michael S. Burns
Officer
|
Sell | 24.2K | $891.4K |
| Oct 20, 2025 | Stephen F Angel
Chief Executive Officer
|
Buy | 55.0K | $2.0M |
| Oct 20, 2025 | Michael S. Burns
Officer
|
Option | 24.2K | $488.1K |
| Sep 15, 2025 | J Steven Whisler
Director
|
Grant | 1.2K | $37.5K |
| Jun 13, 2025 | J Steven Whisler
Director
|
Grant | 1.2K | $37.5K |
Source: TwelveData, from SEC Form 4 filings
CSX stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.